These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 28457884)

  • 1. Substrate mediated enzyme prodrug therapy.
    Fejerskov B; Jarlstad Olesen MT; Zelikin AN
    Adv Drug Deliv Rev; 2017 Sep; 118():24-34. PubMed ID: 28457884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prodrugs in medicinal chemistry and enzyme prodrug therapies.
    Walther R; Rautio J; Zelikin AN
    Adv Drug Deliv Rev; 2017 Sep; 118():65-77. PubMed ID: 28676386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substrate mediated enzyme prodrug therapy.
    Fejerskov B; Zelikin AN
    PLoS One; 2012; 7(11):e49619. PubMed ID: 23152927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Designing metal-contained enzyme mimics for prodrug activation.
    Du B; Li D; Wang J; Wang E
    Adv Drug Deliv Rev; 2017 Sep; 118():78-93. PubMed ID: 28412325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designer bacteria as intratumoural enzyme biofactories.
    Lehouritis P; Hogan G; Tangney M
    Adv Drug Deliv Rev; 2017 Sep; 118():8-23. PubMed ID: 28916496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted enzyme prodrug therapies.
    Schellmann N; Deckert PM; Bachran D; Fuchs H; Bachran C
    Mini Rev Med Chem; 2010 Sep; 10(10):887-904. PubMed ID: 20560876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-step polymer- and liposome-enzyme prodrug therapies for cancer: PDEPT and PELT concepts and future perspectives.
    Scomparin A; Florindo HF; Tiram G; Ferguson EL; Satchi-Fainaro R
    Adv Drug Deliv Rev; 2017 Sep; 118():52-64. PubMed ID: 28916497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumour prodrug development using cytochrome P450 (CYP) mediated activation.
    Patterson LH; McKeown SR; Robson T; Gallagher R; Raleigh SM; Orr S
    Anticancer Drug Des; 1999 Dec; 14(6):473-86. PubMed ID: 10834269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biocatalytic polymer coatings: on-demand drug synthesis and localized therapeutic effect under dynamic cell culture conditions.
    Fejerskov B; Jensen NB; Teo BM; Städler B; Zelikin AN
    Small; 2014 Apr; 10(7):1314-24. PubMed ID: 24376172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective activation of anticancer prodrugs by monoclonal antibody-enzyme conjugates.
    Wallace PM; Senter PD
    Methods Find Exp Clin Pharmacol; 1994 Sep; 16(7):505-12. PubMed ID: 7885077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for enzyme/prodrug cancer therapy.
    Xu G; McLeod HL
    Clin Cancer Res; 2001 Nov; 7(11):3314-24. PubMed ID: 11705842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prodrugs in cancer chemotherapy.
    Connors TA; Knox RJ
    Stem Cells; 1995 Sep; 13(5):501-11. PubMed ID: 8528099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The choice of prodrugs for gene directed enzyme prodrug therapy of cancer.
    Connors TA
    Gene Ther; 1995 Dec; 2(10):702-9. PubMed ID: 8750009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid prodrug nanocarriers in cancer therapy.
    Mura S; Bui DT; Couvreur P; Nicolas J
    J Control Release; 2015 Jun; 208():25-41. PubMed ID: 25617724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbial Enzymes used in Prodrug Activation for Cancer Therapy: Insights and Future Perspectives.
    Dhankhar R; Kawatra A; Mohanty A; Gulati P
    Curr Protein Pept Sci; 2021; 22(7):514-525. PubMed ID: 33290198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site-directed delivery of nitric oxide to cancers.
    Sharma K; Chakrapani H
    Nitric Oxide; 2014 Dec; 43():8-16. PubMed ID: 25124221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy enhances the efficacy of gene-directed enzyme prodrug therapy.
    Christie C; Pomeroy A; Nair R; Berg K; Hirschberg H
    Photodiagnosis Photodyn Ther; 2017 Jun; 18():140-148. PubMed ID: 28257943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PSMA-specific theranostic nanoplex for combination of TRAIL gene and 5-FC prodrug therapy of prostate cancer.
    Chen Z; Penet MF; Krishnamachary B; Banerjee SR; Pomper MG; Bhujwalla ZM
    Biomaterials; 2016 Feb; 80():57-67. PubMed ID: 26706476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prodrugs design based on inter- and intramolecular chemical processes.
    Karaman R
    Chem Biol Drug Des; 2013 Dec; 82(6):643-68. PubMed ID: 23998799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzyme-catalyzed activation of anticancer prodrugs.
    Rooseboom M; Commandeur JN; Vermeulen NP
    Pharmacol Rev; 2004 Mar; 56(1):53-102. PubMed ID: 15001663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.